In Silico Drug Repurposing Approach: Investigation of Mycobacterium tuberculosis FadD32 Targeted by FDA-Approved Drugs

Background: Despite the enormous efforts made towards combating tuberculosis (TB), the disease remains a major global threat. Hence, new drugs with novel mechanisms against TB are urgently needed. Fatty acid degradation protein D32 (FadD32) has been identified as a promising drug target against TB,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ngidi, Nolwazi Thobeka Portia, Machaba, Kgothatso Eugene, Mhlongo, Ndumiso Nhlakanipho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840176/
https://www.ncbi.nlm.nih.gov/pubmed/35163931
http://dx.doi.org/10.3390/molecules27030668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840176/
https://www.ncbi.nlm.nih.gov/pubmed/35163931
http://dx.doi.org/10.3390/molecules27030668

Ejemplares similares